Lambert P W, Stern P H, Avioli R C, Brackett N C, Turner R T, Greene A, Fu I Y, Bell N H
J Clin Invest. 1982 Mar;69(3):722-5. doi: 10.1172/jci110501.
Recent studies provide evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D [1 alpha ,25(OH)2D]. To investigate this possibility, serum vitamin D, 25-hydroxyvitamin D (25-OHD), 24,25-dihydroxyvitamin D [24,25(OH)2D], and 1 alpha ,25(OH)2D were measured in eight adult anephric subjects. All were undergoing hemodialysis and three of them were receiving vitamin D, 50,000 or 100,000 U/d. Serum vitamin D was elevated in two of the patients given vitamin D and was abnormally low in the others. Mean serum 25-OHD was increased in patients given vitamin D (94.0 +/- 7.6 ng/ml) and was normal in the others (16.4 +/- 0.9 ng/ml, P less than 0.001). Mean serum 24,25(OH)2D was normal in patients given vitamin D (1.38 +/- 0.27 ng/ml) and was low in the others (0.25 +/- 0.08 ng/ml, P less than 0.001). Serum 24,25(OH)2D correlated significantly with serum 25-OHD (r = 0.848, P less than 0.01). Mean serum 1 alpha ,25(OH)2D determined by receptor assay was 5.8 +/- 1.9 pg/ml in patients who were not given vitamin D and was 14.1 +/- 0.6 in those who were given vitamin D (P less than 0.001). Serum 1 alpha ,25(OH)2D correlated significantly with serum 25-OHD (r = 0.911, P less than 0.01). Mean serum 1 alpha ,25(OH)2D, measured by bioassay, was 8.3 +/- 1.9 pg/ml in patients who were given vitamin D and was 15.9 +/- 2.4 pg/ml in those who were given vitamin D (P less than 0.05). There was a significant correlation between the values for serum 1 alpha ,25(OH)2D obtained with the two methods (r = 0.728, P less than 0.01). The results (a) provide evidence in man for extrarenal production of both 24,25(OH)2D and, by two independent assays, of 1 alpha , 25(OH)2D, and (b) indicate that serum values of the two dihydroxy metabolites of vitamin D in anephric subjects vary with the serum concentration of the precursor 25-OHD.
近期研究为1α,25 - 二羟基维生素D[1α,25(OH)₂D]的肾外生成提供了证据。为探究这种可能性,对8名成年无肾受试者的血清维生素D、25 - 羟基维生素D(25 - OHD)、24,25 - 二羟基维生素D[24,25(OH)₂D]和1α,25(OH)₂D进行了检测。所有受试者均在接受血液透析,其中3人每日接受50000或100000单位的维生素D。接受维生素D的2名患者血清维生素D升高,其他患者血清维生素D异常低。接受维生素D的患者血清25 - OHD均值升高(94.0±7.6 ng/ml),其他患者血清25 - OHD均值正常(16.4±0.9 ng/ml,P<0.001)。接受维生素D的患者血清24,25(OH)₂D均值正常(1.38±0.27 ng/ml),其他患者血清24,25(OH)₂D均值较低(0.25±0.08 ng/ml,P<0.001)。血清24,25(OH)₂D与血清25 - OHD显著相关(r = 0.848,P<0.01)。通过受体测定法测定,未接受维生素D的患者血清1α,25(OH)₂D均值为5.8±1.9 pg/ml,接受维生素D的患者血清1α,25(OH)₂D均值为14.1±0.6 pg/ml(P<0.001)。血清1α,25(OH)₂D与血清25 - OHD显著相关(r = 0.911,P<0.01)。通过生物测定法测定,接受维生素D的患者血清1α,25(OH)₂D均值为8.3±1.9 pg/ml,接受维生素D(此处重复,疑有误,推测为未接受维生素D)的患者血清1α,25(OH)₂D均值为15.9±2.4 pg/ml(P<0.05)。两种方法测得的血清1α,25(OH)₂D值之间存在显著相关性(r = 0.728,P<0.01)。结果(a)为人体肾外生成24,25(OH)₂D以及通过两种独立测定法生成1α,25(OH)₂D提供了证据,(b)表明无肾受试者中维生素D的两种二羟基代谢产物的血清值随前体25 - OHD的血清浓度而变化。